{"url_path":"/sec/xene/8-k/2026-06-03/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-03","source_url":"https://www.sec.gov/Archives/edgar/data/1582313/0001193125-26-255396-index.html","accession_number":"0001193125-26-255396","cik":"0001582313","ticker":"XENE","issuer_name":"Xenon Pharmaceuticals Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1582313/0001193125-26-255396-index.html","primary_entity_key":"0001582313","primary_entity_name":"Xenon Pharmaceuticals Inc."},"word_count":313,"has_tables":true,"body_markdown":"## Item 5.07 Submission of Matters to a Vote of Security Holders\n\nAt the Annual Meeting, 90,399,636.29 of the Company’s common shares, or approximately 93.54% of the total common shares entitled to vote, were present or represented by proxies and voted on the following proposals, each of which is described in more detail in the Proxy Statement:\n\nProposal One – Election of Directors. The following nominees were elected as directors to serve until the 2027 annual meeting of shareholders or until their respective successors are duly elected and qualified:\n\n \n\nFor\n\nAgainst\n\nBroker\n\nNon-Votes\n\nDawn Svoronos\n\n82,475,281.53\n\n \n\n \n\n \n\n4,517,221.65\n\n \n\n \n\n \n\n3,407,133.11\n\nGillian Cannon\n\n84,844,120.53\n\n \n\n \n\n \n\n2,148,382.65\n\n \n\n \n\n \n\n3,407,133.11\n\nSteven Gannon\n\n86,149,107.53\n\n \n\n \n\n \n\n843,395.65\n\n \n\n \n\n \n\n3,407,133.11\n\nElizabeth Garofalo\n\n84,808,573.53\n\n \n\n \n\n \n\n2,183,929.65\n\n \n\n \n\n \n\n3,407,133.11\n\nJustin Gover\n\n86,290,281.53\n\n \n\n \n\n \n\n702,221.65\n\n \n\n \n\n \n\n3,407,133.11\n\nPatrick Machado\n\n86,603,916.53\n\n \n\n \n\n \n\n388,586.65\n\n \n\n \n\n \n\n3,407,133.11\n\nIan Mortimer\n\n86,524,582.53\n\n \n\n \n\n \n\n467,920.65\n\n \n\n \n\n \n\n3,407,133.11\n\nGary Patou\n\n86,114,511.53\n\n \n\n \n\n \n\n877,991.65\n\n \n\n \n\n \n\n3,407,133.11\n\n \n\nProposal Two – Advisory Vote on Compensation of Named Executive Officers (“Say-on-Pay”). The compensation of the Company’s named executive officers, on an advisory basis, was approved as follows:\n\n \n\nFor\n\nAgainst\n\nAbstain\n\nBroker Non-Votes\n\n82,156,320.53\n\n \n\n \n\n \n\n4,769,025.65\n\n \n\n \n\n \n\n67,157.00\n\n \n\n \n\n \n\n3,407,133.11\n\n \n\nProposal Three – Advisory Vote on Frequency of Say-on-Pay. The frequency of advisory votes on the compensation of the Company’s named executive officers, on an advisory basis, was approved as follows:\n\n \n\n1 Year\n\n2 Year\n\n3 Year\n\n \n\nAbstain\n\n \n\n \n\nBroker Non-Votes\n\n86,918,084.18\n\n \n\n \n\n \n\n2,360.00\n\n \n\n \n\n \n\n43,281.00\n\n \n\n \n\n \n\n28,778.00\n\n \n\n \n\n \n\n3,407,133.11\n\n \n\nProposal Four – 2026 Equity Incentive Plan. The Company's 2026 Equity Incentive Plan was approved as follows:\n\n \n\nFor\n\nAgainst\n\nAbstain\n\nBroker Non-Votes\n\n58,579,810.00\n\n \n\n \n\n \n\n27,570,443.18\n\n \n\n \n\n \n\n842,250.00\n\n \n\n \n\n \n\n3,407,133.11\n\n \n\nProposal Five – Appointment of Auditor. The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the ensuing year was approved as follows:\n\n \n\nFor\n\nWithheld\n\nBroker Non-Votes\n\n90,371,967.64\n\n \n\n \n\n \n\n27,668.65\n\n \n\n \n\n0.00\n\n \n\nProposal Six – Remuneration of Auditor. The authority of the audit committee of the Board to set the remuneration of the auditor for the ensuing year was approved as follows:\n\n \n\nFor\n\nAgainst\n\nAbstain\n\nBroker Non-Votes\n\n90,370,029.64\n\n \n\n \n\n \n\n2,369.65\n\n \n\n \n\n \n\n27,237.00\n\n \n\n \n\n \n\n0.00"}